AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.030
+0.190 (6.69%)
At close: Apr 28, 2026, 4:00 PM EDT
2.970
-0.060 (-1.98%)
After-hours: Apr 28, 2026, 5:10 PM EDT
AC Immune Market Cap
AC Immune has a market cap or net worth of $300.58 million as of April 28, 2026. Its market cap has increased by 102.27% in one year.
Market Cap
300.58M
Enterprise Value
190.53M
1-Year Change
102.27%
Ranking
Category
Stock Price
$3.03
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $300.58M, a decrease of -65.35%. That is a compound annual growth rate of -10.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 288.90M | -8.81% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 317.04M |
| NervGen Pharma | 312.39M |
| Cabaletta Bio | 311.15M |
| Anavex Life Sciences | 310.91M |
| Abeona Therapeutics | 304.32M |
| Foghorn Therapeutics | 300.55M |
| Cellectis | 291.55M |
| LENZ Therapeutics | 290.97M |